1 |
MET
| 2件: Transcriptional misregulation in cancer Transcriptional misregulation in cancer, Renal cell carcinoma | D10062
D10062
|
Cabozantinib
| 1件: 34 34 |
2 |
PIK3CA
| 15件: Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Renal cell carcinoma, Small cell lung cancer | D11011
D11011
|
Alpelisib
| 1件: 138 138 |
3 |
PIK3CA
| 15件: Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Renal cell carcinoma, Small cell lung cancer | D11158
D11158
|
Leniolisib
| 2件: 53 53, 65 |
4 |
PIK3CB
| 15件: Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Renal cell carcinoma, Small cell lung cancer | D11158
D11158
|
Leniolisib
| 2件: 53 53, 65 |
5 |
PIK3CD
| 15件: Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Renal cell carcinoma, Small cell lung cancer | D11158
D11158
|
Leniolisib
| 2件: 53 53, 65 |
6 |
PIK3CD
| 15件: Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Salmonella infection, Yersinia infection, Viral carcinogenesis, Renal cell carcinoma, Small cell lung cancer | D11437
D11437
|
Parsaclisib
| 3件: 35 35, 53, 61 |
7 |
MAP2K1
| 13件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Thyroid hormone signaling pathway, Salmonella infection, Yersinia infection, Renal cell carcinoma, Thyroid cancer | D09666
D09666
|
Selumetinib
| 1件: 34 34 |
8 |
MAP2K1
| 13件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Thyroid hormone signaling pathway, Salmonella infection, Yersinia infection, Renal cell carcinoma, Thyroid cancer | D10175
D10175
|
Trametinib
| 4件: 2 2, 34, 279, 280 |
9 |
MAP2K1
| 13件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Thyroid hormone signaling pathway, Salmonella infection, Yersinia infection, Renal cell carcinoma, Thyroid cancer | D10405
D10405
|
Cobimetinib
| 1件: 280 280 |
10 |
MAP2K1
| 13件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Thyroid hormone signaling pathway, Salmonella infection, Yersinia infection, Renal cell carcinoma, Thyroid cancer | D10604
D10604
|
Binimetinib
| 1件: 34 34 |
11 |
MAP2K1
| 13件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Thyroid hormone signaling pathway, Salmonella infection, Yersinia infection, Renal cell carcinoma, Thyroid cancer | D11675
D11675
|
Mirdametinib
| 1件: 34 34 |
12 |
MAP2K2
| 11件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Thyroid hormone signaling pathway, Salmonella infection, Yersinia infection, Renal cell carcinoma, Thyroid cancer | D09666
D09666
|
Selumetinib
| 1件: 34 34 |
13 |
MAP2K2
| 11件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Thyroid hormone signaling pathway, Salmonella infection, Yersinia infection, Renal cell carcinoma, Thyroid cancer | D10175
D10175
|
Trametinib
| 4件: 2 2, 34, 279, 280 |
14 |
MAP2K2
| 11件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Thyroid hormone signaling pathway, Salmonella infection, Yersinia infection, Renal cell carcinoma, Thyroid cancer | D10405
D10405
|
Cobimetinib
| 1件: 280 280 |
15 |
MAP2K2
| 11件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Thyroid hormone signaling pathway, Salmonella infection, Yersinia infection, Renal cell carcinoma, Thyroid cancer | D10604
D10604
|
Binimetinib
| 1件: 34 34 |
16 |
MAP2K2
| 11件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Thyroid hormone signaling pathway, Salmonella infection, Yersinia infection, Renal cell carcinoma, Thyroid cancer | D11675
D11675
|
Mirdametinib
| 1件: 34 34 |
17 |
RAF1
| 10件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, T cell receptor signaling pathway, Serotonergic synapse, Thyroid hormone signaling pathway, Salmonella infection, Tuberculosis, Renal cell carcinoma | D08524
D08524
|
Sorafenib
| 2件: 34 34, 86 |
18 |
BRAF
| 4件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Serotonergic synapse, Renal cell carcinoma, Thyroid cancer | D08524
D08524
|
Sorafenib
| 2件: 34 34, 86 |
19 |
BRAF
| 4件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Serotonergic synapse, Renal cell carcinoma, Thyroid cancer | D10064
D10064
|
Dabrafenib
| 1件: 34 34 |
20 |
TGFB1
| 6件: TGF-beta signaling pathway TGF-beta signaling pathway, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Renal cell carcinoma, Rheumatoid arthritis | D09620
D09620
|
Fresolimumab
| 3件: 51 51, 85, 222 |
21 |
TGFB2
| 5件: TGF-beta signaling pathway TGF-beta signaling pathway, Toxoplasmosis, Tuberculosis, Renal cell carcinoma, Rheumatoid arthritis | D09620
D09620
|
Fresolimumab
| 3件: 51 51, 85, 222 |
22 |
TGFB3
| 5件: TGF-beta signaling pathway TGF-beta signaling pathway, Toxoplasmosis, Tuberculosis, Renal cell carcinoma, Rheumatoid arthritis | D09620
D09620
|
Fresolimumab
| 3件: 51 51, 85, 222 |
23 |
VEGFA
| 3件: VEGF signaling pathway VEGF signaling pathway, Renal cell carcinoma, Rheumatoid arthritis | D05697
D05697
|
Ranibizumab
| 4件: 34 34, 166, 227, 301 |
24 |
VEGFA
| 3件: VEGF signaling pathway VEGF signaling pathway, Renal cell carcinoma, Rheumatoid arthritis | D06409
D06409
|
Bevacizumab
| 6件: 13 13, 34, 85, 87, 227, 280 |
25 |
VEGFA
| 3件: VEGF signaling pathway VEGF signaling pathway, Renal cell carcinoma, Rheumatoid arthritis | D09574
D09574
|
Aflibercept
| 2件: 90 90, 166 |